Vertex Pharmaceuticals | 221.3500 / +1.94% |
Date/Time | 04/15 / 16:09 |
Chg. / Chg.(%) | 4.2200 / +1.94% |
Bid | 221.3500 / 100 |
Ask | 221.5000 / 200 |
Open | 218.5200 |
Previous Close | 217.1300 |
High | 222.0250 |
Low | 218.0000 |
Volume [USD] | 44,909,088.3170 |
Volume [Units] | 276,857 |
Price fixings | 1350 |
ISIN | US92532F1003 |
Security | VRTX |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 221.3500 | ![]() |
276,857 |
Cboe US | 221.35 | ![]() |
23,557 |
IEX | 221.23 | ![]() |
11,569 |
TradeGate | 184.960 | ![]() |
772 |
Stuttgart | 185.120 | ![]() |
675 |
London Inter.. | 220.44 | ![]() |
431 |
Moscow | 16,856.00 | ![]() |
134 |
Vienna Globa.. | 184.42 | ![]() |
110 |
gettex | 184.780 | ![]() |
83 |
Hamburg | 180.94 | ![]() |
24 |
Xetra | 183.16 | ![]() |
3 |
Frankfurt | 181.0200 | ![]() |
0 |
München | 180.94 | ![]() |
0 |
Düsseldorf | 185.28 | ![]() |
0 |
Berlin | 181.06 | ![]() |
0 |
Hannover | 180.96 | ![]() |
0 |
Lang & Schwa.. | 184.640 | ![]() |
|
Mexico | 4,383.00 | ![]() |
347 |
News
- CRISPR Therapeutics Presents Preclinical Data at AACR 2021 Supporting CD70 Knockout as a Novel Approach to Increasing CAR-T Cell Function
04/10/2021 / 14:31 - GlobeNewswire - CRISPR Therapeutics to Participate in the 20th Annual Needham Virtual Healthcare Conference
04/06/2021 / 14:00 - GlobeNewswire - Arbor Biotechnologies Names Devyn Smith, Ph.D., as CEO
04/01/2021 / 14:00 - GlobeNewswire - COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors
04/01/2021 / 13:01 - GlobeNewswire - BrightInsight Announces $101M in Series C Funding led by General Catalyst
03/30/2021 / 14:30 - GlobeNewswire